Skip to main content
. 2018 Sep 27;3:7. doi: 10.1186/s41073-018-0052-4

Table 1.

Submissions by editorial decision and by the reporting guidelines authors said they used

Editorial decision All Submissions STROBE ARRIVE MIQE CONSORT REMARK PRISMA STARD MOOSE BRISQ STREGA CHEERS
All, no. (%) 2209 (100) 531 (24.0) 150 (6.8) 54 (2.4) 96 (4.3) 140 (6.3) 133 (6.0) 65 (2.9) 26 (1.2) 34 (1.5) 23 (1.0) 4 (0.2)
 Sent to peer review 396 (17.9) 86 (3.9) 28 (1.3) 5 (0.2) 23 (1.0) 24 (1.1) 25 (1.1) 10 (0.5) 7 (0.3) 4 (0.2) 7 (0.3) 0 (0.0)
  Rejected after peer review 255 (11.5) 36 (1.6) 14 (0.6) 3 (0.1) 7 (0.3) 12 (0.5) 16 (0.7) 5 (0.2) 1 (0.0) 3 (0.1) 4 (0.2) 0 (0.0)
  Not rejected after peer review 141 (6.4) 50 (2.3) 14 (0.6) 2 (0.1) 16 (0.7) 12 (0.5) 9 (0.4) 5 (0.2) 6 (0.3) 1 (0.0) 3 (0.1) 0 (0.0)
 Not sent to peer review 1813 (82.1) 445 (20.1) 122 (5.5) 49 (2.2) 73 (3.3) 116 (5.3) 108 (4.9) 55 (2.5) 19 (0.9) 30 (1.4) 16 (0.7) 4 (0.2)
  Reject without review 98 (4.4) 22 (1.0) 1 (0.0) 1 (0.0) 2 (0.1) 2 (0.1) 8 (0.4) 2 (0.1) 1 (0.0) 2 (0.1) 0 (0.0) 2 (0.1)
  Priority reject 1715 (77.6) 423 (19.1) 121 (5.5) 48 (2.2) 71 (3.2) 114 (5.2) 100 (4.5) 53 (2.4) 18 (0.8) 28 (1.3) 16 (0.7) 2 (0.1)

STROBE Strengthening-Reporting of Observational-Studies in Epidemiology, ARRIVE Animal Research: Reporting In Vivo Experiments, MIQE Minimum Information for Publication of Quantitative Real-Time PCR Experiments, CONSORT Consolidated Standards of Reporting Trials, REMARK Reporting recommendations for tumour Marker prognostic studies, PRISMA Preferred Reporting Items for Systematic Reviews and Meta-analyses, STARD studies of diagnostic accuracy, MOOSE Meta-analyses of Observational Studies, BRISQ Biospecimen reporting for improved study quality, STREGA Strengthening the Reporting of Genetic Association Studies , an extension to STROBE; and Consolidated Health Economic Evaluation Reporting Standards (CHEERS)